The trajectory of companies tied to the drug's legacy presents a complex investment picture . While the initial success generated substantial gains, generic alternatives have significantly impacted market https://knockoff468725.blogrelation.com/48422530/copyright-s-flagship-product-and-big-pharma-a-uncertain-opportunity